Author

L. Wetherill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. A. Lekan· 1 shared A. Bloy· 1 shared A. Deshpande· 1 shared A. Duttargi· 1 shared A. Macdonald· 1 shared A. Samson· 1 shared A. W. Tarr· 1 shared B. J. King· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Lekan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer

Z. X. Malchiodi, A. A. Lekan, R. K. Suter, A. Deshpande, I. Peran, B. T. Harris, A. Duttargi, M.-J. Chien, S. Hariharan, L. Wetherill, S. Arslan, S. A. Jablonski, W. J. Ho, M. Afifi, E. J. Fertig, L. M. Weiner

The paper identifies periductal fibroblast density as a key factor in immune exclusion in pancreatic cancer, showing that CD44-dependent stromal checkpoints restrict leukocyte access to tumor epithelium.

bioRxiv · May 23, 2024Cancer Biology

Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy

J. Shaw, R. Gosein, M. M. Kalita, J. Kankanala, D. R. Mahato, T. Foster, C. Scott, E. Brown, B. J. King, M. Bentham, L. Wetherill, A. Bloy, A. Samson, M. Harris, J. Mankouri, , S. Griffin

The paper designs a rationally derived inhibitor of HCV p7 channel activity, revealing its dual role in virus entry and infection spread, and highlights its potential for bimodal antiviral therapy.

bioRxiv · Oct 7, 2019Microbiology